146 related articles for article (PubMed ID: 23886684)
1. Synthesis of quaternary α-amino acid-based arginase inhibitors via the Ugi reaction.
Golebiowski A; Whitehouse D; Beckett RP; Van Zandt M; Ji MK; Ryder TR; Jagdmann E; Andreoli M; Lee Y; Sheeler R; Conway B; Olczak J; Mazur M; Czestkowski W; Piotrowska W; Cousido-Siah A; Ruiz FX; Mitschler A; Podjarny A; Schroeter H
Bioorg Med Chem Lett; 2013 Sep; 23(17):4837-41. PubMed ID: 23886684
[TBL] [Abstract][Full Text] [Related]
2. 2-Substituted-2-amino-6-boronohexanoic acids as arginase inhibitors.
Golebiowski A; Paul Beckett R; Van Zandt M; Ji MK; Whitehouse D; Ryder TR; Jagdmann E; Andreoli M; Mazur A; Padmanilayam M; Cousido-Siah A; Mitschler A; Ruiz FX; Podjarny A; Schroeter H
Bioorg Med Chem Lett; 2013 Apr; 23(7):2027-30. PubMed ID: 23453840
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of new omega-borono-alpha-amino acids as rat liver arginase inhibitors.
Busnel O; Carreaux F; Carboni B; Pethe S; Goff SV; Mansuy D; Boucher JL
Bioorg Med Chem; 2005 Apr; 13(7):2373-9. PubMed ID: 15755639
[TBL] [Abstract][Full Text] [Related]
4. Insights into the Structural Requirements of 2(S)-Amino-6-Boronohexanoic Acid Derivatives as Arginase I Inhibitors: 3D-QSAR, Docking, and Interaction Fingerprint Studies.
Velázquez-Libera JL; Navarro-Retamal C; Caballero J
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30274146
[TBL] [Abstract][Full Text] [Related]
5. Arginase-boronic acid complex highlights a physiological role in erectile function.
Cox JD; Kim NN; Traish AM; Christianson DW
Nat Struct Biol; 1999 Nov; 6(11):1043-7. PubMed ID: 10542097
[TBL] [Abstract][Full Text] [Related]
6. Biochemical and functional profile of a newly developed potent and isozyme-selective arginase inhibitor.
Baggio R; Emig FA; Christianson DW; Ash DE; Chakder S; Rattan S
J Pharmacol Exp Ther; 1999 Sep; 290(3):1409-16. PubMed ID: 10454520
[TBL] [Abstract][Full Text] [Related]
7. Design of amino acid aldehydes as transition-state analogue inhibitors of arginase.
Shin H; Cama E; Christianson DW
J Am Chem Soc; 2004 Aug; 126(33):10278-84. PubMed ID: 15315440
[TBL] [Abstract][Full Text] [Related]
8. Design of amino acid sulfonamides as transition-state analogue inhibitors of arginase.
Cama E; Shin H; Christianson DW
J Am Chem Soc; 2003 Oct; 125(43):13052-7. PubMed ID: 14570477
[TBL] [Abstract][Full Text] [Related]
9. The effects of arginase inhibitor on lung oxidative stress and inflammation caused by pneumoperitoneum in rats.
Cho JS; Oh YJ; Kim OS; Na S
BMC Anesthesiol; 2015 Sep; 15():129. PubMed ID: 26415531
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of human arginase I at 1.29-A resolution and exploration of inhibition in the immune response.
Di Costanzo L; Sabio G; Mora A; Rodriguez PC; Ochoa AC; Centeno F; Christianson DW
Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13058-63. PubMed ID: 16141327
[TBL] [Abstract][Full Text] [Related]
11. Discovery of
Van Zandt MC; Jagdmann GE; Whitehouse DL; Ji M; Savoy J; Potapova O; Cousido-Siah A; Mitschler A; Howard EI; Pyle AM; Podjarny AD
J Med Chem; 2019 Sep; 62(17):8164-8177. PubMed ID: 31408339
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of arginase from Leishmania mexicana and implications for the inhibition of polyamine biosynthesis in parasitic infections.
D'Antonio EL; Ullman B; Roberts SC; Dixit UG; Wilson ME; Hai Y; Christianson DW
Arch Biochem Biophys; 2013 Jul; 535(2):163-76. PubMed ID: 23583962
[TBL] [Abstract][Full Text] [Related]
13. Discovery of (R)-2-amino-6-borono-2-(2-(piperidin-1-yl)ethyl)hexanoic acid and congeners as highly potent inhibitors of human arginases I and II for treatment of myocardial reperfusion injury.
Van Zandt MC; Whitehouse DL; Golebiowski A; Ji MK; Zhang M; Beckett RP; Jagdmann GE; Ryder TR; Sheeler R; Andreoli M; Conway B; Mahboubi K; D'Angelo G; Mitschler A; Cousido-Siah A; Ruiz FX; Howard EI; Podjarny AD; Schroeter H
J Med Chem; 2013 Mar; 56(6):2568-80. PubMed ID: 23472952
[TBL] [Abstract][Full Text] [Related]
14. Classical and slow-binding inhibitors of human type II arginase.
Colleluori DM; Ash DE
Biochemistry; 2001 Aug; 40(31):9356-62. PubMed ID: 11478904
[TBL] [Abstract][Full Text] [Related]
15. Arginase and autoimmune inflammation in the central nervous system.
Xu L; Hilliard B; Carmody RJ; Tsabary G; Shin H; Christianson DW; Chen YH
Immunology; 2003 Sep; 110(1):141-8. PubMed ID: 12941151
[TBL] [Abstract][Full Text] [Related]
16. Arginase inhibition promotes wound healing in mice.
Kavalukas SL; Uzgare AR; Bivalacqua TJ; Barbul A
Surgery; 2012 Feb; 151(2):287-95. PubMed ID: 21975291
[TBL] [Abstract][Full Text] [Related]
17. Novel macrocyclic HCV NS3 protease inhibitors derived from α-amino cyclic boronates.
Li X; Zhang YK; Liu Y; Ding CZ; Zhou Y; Li Q; Plattner JJ; Baker SJ; Zhang S; Kazmierski WM; Wright LL; Smith GK; Grimes RM; Crosby RM; Creech KL; Carballo LH; Slater MJ; Jarvest RL; Thommes P; Hubbard JA; Convery MA; Nassau PM; McDowell W; Skarzynski TJ; Qian X; Fan D; Liao L; Ni ZJ; Pennicott LE; Zou W; Wright J
Bioorg Med Chem Lett; 2010 Oct; 20(19):5695-700. PubMed ID: 20801653
[TBL] [Abstract][Full Text] [Related]
18. Binding of α,α-disubstituted amino acids to arginase suggests new avenues for inhibitor design.
Ilies M; Di Costanzo L; Dowling DP; Thorn KJ; Christianson DW
J Med Chem; 2011 Aug; 54(15):5432-43. PubMed ID: 21728378
[TBL] [Abstract][Full Text] [Related]
19. Effect of the mammalian arginase inhibitor 2(S)-amino-6-boronohexanoic acid on Bacillus anthracis arginase.
Tsai P; Cao GL; Tomczuk B; Suzdak PD; Cross AS; Shapiro P; Rosen GM
Curr Microbiol; 2012 Apr; 64(4):379-84. PubMed ID: 22271269
[TBL] [Abstract][Full Text] [Related]
20. Arginase inhibition protects against allergen-induced airway obstruction, hyperresponsiveness, and inflammation.
Maarsingh H; Zuidhof AB; Bos IS; van Duin M; Boucher JL; Zaagsma J; Meurs H
Am J Respir Crit Care Med; 2008 Sep; 178(6):565-73. PubMed ID: 18583571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
